dr. dang on the destiny-breast01 trial in her2 metastatic breast cancer
Published 4 years ago • 736 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
1:07
dr. hamilton on the destiny-breast01 trial in her2 breast cancer
-
1:00
dr. dang on the significance of the myl-1401o biosimilar in her2-positive metastatic breast cancer
-
4:56
her2 mbc: study design and results of destiny-breast01
-
4:34
her2 mbc: addressing ild in the destiny-breast01 study
-
3:36
trastuzumab deruxtecan in patients with breast cancer and brain metastases in destiny-breast01
-
1:09
dr. dang on neratinib in patients with her2 breast cancer
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
1:42
kevin kalinsky, md, shares thoughts on the destiny-breast01 clinical trial from sabcs 2020
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
1:43
dr hamilton on implications of destiny-breast06 on the her2-low breast cancer paradigm
-
3:31
hope rugo, md, examines data from the destiny-breast01 clinical study presented at sabcs 2020
-
0:48
highlights from esmo: destiny-breast03
-
1:17
comment: phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer pts
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
1:22
dr. o'shaughnessy on the utility of capivasertib in targeting akt in breast cancer